The results indicated that the overexpression of LOX, LOXL1, LOXL2, LOXL3, and LOXL4 mRNA in serous ovarian carcinoma patients was related to unfavorable OS and PFS. The gene discussed is LOXL1; the disease is ovarian serous carcinoma.